 SAN DIEGO, April 28, 2021 PRNewswire -- Evofem Biosciences, Inc., NASDAQ: EVFM today announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi lactic acid, citric acid, potassium bitartrate will be presented at the 2021 American College of Obstetricians and Gynecologists ACOG Annual Clinical and Scientific Meeting ACSM. The meeting will be conducted virtually from April 30 - May 2, 2021. 